Summary:

India is quickly emerging as a global leader in the aesthetic medicine industry, with revenues projected to triple to $3.02 billion by 2029. This growth is driven by increasing interest in noninvasive procedures like Botox and fillers, rising disposable incomes, and a health-conscious population. According to the International Society of Aesthetic Plastic Surgery, non-surgical treatments surpassed surgical procedures in 2020. Botulinum toxin remains the most popular nonsurgical treatment, with over 9 million procedures worldwide, reflecting a 26.1% rise, followed by 4.3 million hyaluronic acid treatments.

Currently, women account for 85.7% of the aesthetic medicine consumer base, though acceptance among men and millennials is increasing, altering the industry's demographics. India’s market is valued at approximately $1.62 billion, with a 13.2% CAGR. Dr. Rashmi Shetty notes a shift in societal attitudes, emphasizing that these treatments are now seen as beneficial for self-esteem and well-being and are no longer considered taboo.

Source: IBEF 

Disclaimer: The information on this website comes from the India Brand Equity Foundation (IBEF), a reliable source for thorough insights into numerous areas of the Indian economy. While we aim to offer accurate and up-to-date information, the views, opinions, and analyses stated herein are solely those of the authors and contributors and do not necessarily represent IBEF's official stance or position. Readers should check information from credible sources and use their own discretion when relying on content provided on this site. We assume no responsibility or liability for the supplied content, including its accuracy, completeness, and usefulness.